Trials / Completed
CompletedNCT00677209
The Effect of Autologous Autovaccine in Patients With Allergy on House-dust-mite
Frankfurt Investigator-initiated Autovaccine-study
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 8 (actual)
- Sponsor
- Johann Wolfgang Goethe University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 35 Years
- Healthy volunteers
- Not accepted
Summary
House dust mite allergy is a common problem, resulting in asthma, chronic swelling of the eyes, and running nose. The investigators test a possibility to immunize subjects sensitized against house dust mite with extracts from their own gut bacteria "auto-vaccination".
Detailed description
see above
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Injection of autovaccine (Autovaccine Symbiopharm) | increasing dosage schedule, six different concentrations, application over six weeks, 2 weeks break, another six weeks, 2 weeks break, than challenge with inhalative house dust mite extract |
Timeline
- Start date
- 2006-07-01
- Primary completion
- 2008-08-01
- Completion
- 2010-12-01
- First posted
- 2008-05-14
- Last updated
- 2010-12-29
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT00677209. Inclusion in this directory is not an endorsement.